A new immunotherapy approach has shown promise in treating various types of cancer, including blood, pancreatic, and brain cancer, in early trials. The treatment involves the use of immune cells, including genome-edited and CAR T-cell therapy, which have produced lasting results in some cases. However, the specific details and applications of the treatment vary across different reports, with some outlets highlighting its potential for certain types of cancer, such as leukemia and pancreatic cancer.